Q3 2017 Sentiment Biolase Inc (NASDAQ:BIOL)

January 8, 2018 - By Adrian Mccoy

  Q3 2017 Sentiment Biolase Inc (NASDAQ:BIOL)

Sentiment for Biolase Inc (NASDAQ:BIOL)

Biolase Inc (NASDAQ:BIOL) institutional sentiment increased to 0.79 in Q3 2017. Its up 0.16, from 0.63 in 2017Q2. The ratio has increased, as 11 funds increased and opened new holdings, while 14 decreased and sold their stakes in Biolase Inc. The funds in our partner’s database now own: 29.45 million shares, up from 28.33 million shares in 2017Q2. Also, the number of funds holding Biolase Inc in their top 10 holdings was flat from 1 to 1 for the same number . Sold All: 7 Reduced: 7 Increased: 5 New Position: 6.

BIOLASE, Inc., a medical device company, develops, makes, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company has market cap of $34.06 million. The firm offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It currently has negative earnings. The Company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications.

The stock increased 1.82% or $0.008 during the last trading session, reaching $0.448. About 182,946 shares traded. BIOLASE, Inc. (NASDAQ:BIOL) has risen 0.85% since January 8, 2017 and is uptrending. It has underperformed by 15.85% the S&P500.

Oracle Investment Management Inc holds 1.81% of its portfolio in BIOLASE, Inc. for 18.32 million shares. Birchview Capital Lp owns 1.29 million shares or 0.4% of their US portfolio. Moreover, Trellus Management Company Llc has 0.31% invested in the company for 375,028 shares. The Massachusetts-based Camber Capital Management Llc has invested 0.2% in the stock. Teton Advisors Inc., a New York-based fund reported 341,461 shares.#img1#

More important recent BIOLASE, Inc. (NASDAQ:BIOL) news were published by: Businesswire.com which released: “BIOLASE Announces Terms of Rights Offering” on November 03, 2017, also Prnewswire.com published article titled: “BIOLASE Receives Awards From Leading Industry Organizations For Its Dental …”, Businesswire.com published: “BIOLASE Names Jonathan T. Lord Chairman of the Board” on September 05, 2017. More interesting news about BIOLASE, Inc. (NASDAQ:BIOL) was released by: Businesswire.com and their article: “BIOLASE Announces Plans for Rights Offering to Stockholders” with publication date: September 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>